SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-16-503517
Filing Date
2016-03-14
Accepted
2016-03-14 16:20:49
Documents
5
Effectiveness Date
2016-03-14

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d288825ds8.htm S-8 33601
2 EX-5.1 d288825dex51.htm EX-5.1 6902
3 EX-23.1 d288825dex231.htm EX-23.1 1235
4 GRAPHIC g288825g07l96.gif GRAPHIC 2266
5 GRAPHIC g288825g39d86.gif GRAPHIC 8012
  Complete submission text file 0001193125-16-503517.txt   57206
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210171 | Film No.: 161504084
SIC: 2834 Pharmaceutical Preparations